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A 13-year-old girl was diagnosed with non-cystic fibrosis (CF)-
related multifocal bronchiectasis accompanied by nephrotic-range 
proteinuria of unknown cause. On renal biopsy, there were many 
segmental homogeneous deposits of amyloid tissue with positive 
Congo red staining in the glomeruli and interstitium. On electron 
microscopy, relatively straight, non-branching, randomly arranged 
amyloid fibrils were showed in the mesangium of the glomeruli. 
These fibrils were approximately 10 nm in diameter, compatible with 
secondary amyloidosis. Her level of serum amyloid A was remarkably 
elevated. To our knowledge, this girl is the first case of secondary renal 
amyloidosis induced by bronchiectasis in Korean children. 
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Introduction
Renal amyloidosis is characterized by the extracellular deposition 
of amyloid, a proteinaceous fibrilar material, presenting positive 
staining of Congo red, in the kidney
1). Primary amyloidosis is 
extremely rare in children and the causes of secondary amyloidosis 
in children include familiar Mediterranean fever (FMF), 
rheumatoid arthritis (RA), ankylosing spondylitis, inflammatory 
bowel disease, chronic infection such as tuberculosis, and cystic 
fibrosis (CF)
2). Bronchiectasis in children is most commonly 
associated with CF in industrialized countries, although there are 
many etiologies for bronchiectasis unrelated to CF
3). Herein, we 
present a 13-year-old Korean girl who developed secondary renal 
amyloidosis by non-CF related bronchiectasis.
Case report
A 13-year-old girl was admitted with dyspnea due to severe 
pneumonia and respiratory failure. On past medical history, she 
developed bronchiolitis at the early age of 1 month for the first 
time. Since that time, pneumonia and bronchiolitis recurred several 
times a year up to school age. The medical history of her family 
was unremarkable. When she was 10-years-old, she was referred to 
our department for the evaluation of abnormal infiltration of both 
lung fields visible on a chest X-ray. At that time surgical removal 
of nasal polyps due to chronic sinusitis was decided and a chest 
X-ray was checked as one of preoperative evaluations. However, she 
had no respiratory symptoms or signs and her breathing sound on 
auscultation was clear. Several evaluations to find the causes of this 
abnormal infiltration were performed, especially by tuberculosis 
tests. But AFB stain, PCR and culture of sputum and urine were 
all negative and a Mantoux test was also negative. So, she was 
diagnosed with simple infectious bronchiolitis with bronchitis. 
After that, she was followed up irregularly during the next 3 years. 
Several months before admission, she had been also diagnosed with 
hypothyroidism and gastritis at another hospital.
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On physical examination, she had lip cyanosis and clubbing 
fingers. A computed tomography (CT) scan showed multifocal 
bronchiectasis and extensive bronchiolitis (Fig. 1). In the course 
of the admission, she was supported by mechanical ventilation for 
nearly one month and by the parenteral treatment of antibiotics 
for pseudomonas infection proven by culture of sputum. She has 
received chest physiotherapy to improve mucus clearance with 
mucolytic drug. Systemic and inhaled corticosteroids were also 
applied for short-term period. On admission, the laboratory findings 
of this girl were as follows: pH 7.37 and pCO2 35 mmHg on arterial 
blood gas analysis, white blood cell count 22,860/mm
3, hemoglobin 
9.3 g/dL, platelet count 757,000/mm
3, erythrocyte sedimentation 
rate 83 mm/hour, C-reactive protein 11.18 mg/dL, blood urea 
nitrogen (BUN) 4.4 mg/dL, serum creatinine 0.42 mg/dL, total 
protein 4.8 g/dL, and albumin 1.8 g/dL. Cold agglutinin and 
antibody to mycoplasma were negative. Urinalysis showed protein 
(++), occult blood (+) and urine protein during 24 hours was 2,090 
mg/m2. To elucidate the cause of bronchiectasis, several additional 
tests were also performed. Immunologic studies showed normal 
levels of immunoglobulin (Ig) G, IgA, IgM and α 1-antitrypsin 
except for a mild elevation of IgE. Several weeks later a sweat test 
performed as one of the evaluations of CF was not specific and there 
was no mutation of the CF transmembrane conductance regulator 
(CFTR) gene. After confirming non-CF related bronchiectasis, 
a mucosal biopsy of the nasal cavity was performed to rule out 
primary ciliary dyskinesia and the result was normal on an electron 
microscopy (EM). Six months later after an improvement of her 
respiratory condition, an ultrasonogram-guided renal biopsy was 
performed to reveal the cause of proteinuria. On light microscopy, 
there were many segmental homogeneous deposits of amyloid 
Fig. 1. Computed tomography shows multifocal bronchiectasis and 
extensive bronchiolitis in both lung fields.
Fig. 2. Many segmental homogeneous deposits of amyloid tissue on 
light microscopy in the mesangium of the glomeruli (×100, Congo red).  
Fig. 3. Electron microscopy shows relatively straight, non-
branching, randomly arranged amyloid fibrils (approximately 
10 nm in diameter) in the mesangium of the glomerulus (A: 
×12,000, B: ×15,000). A
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with positive Congo red staining in the glomeruli and interstitium 
(Fig. 2). Immunohistochemistry revealed positive staining of 
the AA amyloid and immunofluorescent microscopy showed 
negative staining of IgG, IgA, IgM, C3 and fibrinogen. EM 
showed relatively straight, non-branching, randomly arranged 
amyloid fibrils in the mesangium of the glomeruli and these fibrils 
were approximately 10 nm in diameter (Fig. 3A, 3B), compatible 
with secondary amyloidosis. At that time, serum amyloid A was 
remarkably elevated (62.0 mg/L, normal range: <8.0 mg/L).
At recent follow-up (22 months after admission), BUN and 
serum creatinine were mildly elevated (34 mg/dL and 1.2 mg/dL, 
respectively) and proteinuria was improved with the results of the 
protein (+) in dipstick and decreased spot urine protein-creatinine 
ratio. The repeated chest film and CT scans showed no remarkable 
interval change and serum amyloid A slightly decreased than before 
(26.9 mg/L).
Discussion
Amyloidosis is a group of diseases characterized by extracellular 
deposition of insoluble fibrous amyloid proteins which can 
be identified in biopsy specimens both by their characteristic 
appearance on the EM and by their ability to bind Congo red. 
And the major sites of amyloid deposition are in kidney, heart, 
skin, gastrointestinal tract, and liver
4). Clinically evident renal 
involvement mainly occurs in immunoglobulin light chains in 
primary systemic amyloidosis (AL) or amyloid A in secondary 
amyloidosis (AA)
4). Because primary amyloidosis is extremely rare 
in children
2), secondary amyloidosis is the major pattern of renal 
amyloidosis during childhood. 
Causes of secondary amyloidosis in children include FMF, 
RA, ankylosing spondylitis, inflammatory bowel disease, chronic 
infections such as tuberculosis, CF
2), and chronic granulomatous 
disease
5). Although FMF is the most common cause of secondary 
amyloidosis in childhood
6), FMF is highly prevalent in some 
limited areas such as the Middle East and Turkey
1, 7). Tuberculosis 
and other chronic infections including bronchiectasis are other 
leading causes of systemic amyloidosis, followed in frequency by 
RA in other areas, especially developing countries
1).
The clinical manifestations of renal amyloidosis vary with the site 
of involvement and most often includes asymptomatic proteinuria 
and nephrotic syndrome, as well as renal insufficiency
1). End-stage 
renal disease (ESRD) is the cause of death in a minority of patients. 
Moon et al
8) reported the first case of secondary renal amyloidosis 
in a 12-year-old girl with juvenile rheumatoid arthritis.
Conditions that predispose bronchiectasis in children include 
CF, ciliary dyskinesia, hypogammaglobulinemia, proximal 
airway narrowing, and Kartagener syndrome
3, 9). Among these 
etiologies, CF is the most common cause of bronchiectasis in 
children, especially, in industrialized countries, although there are 
many etiologies for bronchiectasis unrelated to CF
3). However, 
because CF is very rare in Korea, the incidence of bronchiectasis 
in Korean children is extremely low
10). Lung damage occurring 
after lower respiratory infection is still the most common cause of 
bronchiectasis in developing countries and a great problem in some 
parts of the world
11). In our patient, she had a history of recurrent 
respiratory infections such as pneumonia, bronchiolitis and 
bronchitis from infancy. Moreover, she was not found to have any 
other underlying etiology. Therefore, it is likely that an underlying 
etiology of the bronchiectasis in our patient is postinfectious. 
Development and progression of secondary amyloidosis, in 
general, needs the long-term continuation of primary inflammatory 
conditions that induce the elevation of amyloid protein as one of 
the acute phase reactants. It was reported that the mean duration 
of bronchiectasis in patients with secondary amyloidosis to cause 
chronic renal failure was 22 years
12). Therefore, it is very difficult 
to find patients with secondary renal amyloidosis complicated by 
long-standing, non-CF related bronchiectasis during childhood in 
Korea. 
In the pathogenesis of secondary amyloidosis, the importance 
of increased serum amyloid A (SAA) has been demonstrated by 
the correlation between SAA concentration and disease course in 
patients with established amyloidosis
13). The outcomes were variable 
but, among those in whom the level of SAA was persistently above 
50 mg/L, the amyloid load usually increased and organ function 
deteriorated
13). Actually, in our patient, her SAA was highly elevated 
(62.0 mg/L) and this confirmed the existence of uncontrolled 
systemic inflammation. If untreated, AA amyloidosis is a serious 
disease with a significant mortality due to ESRD, infection, 
heart failure, bowel perforation, or gastrointestinal bleeding. In a 
Japanese study of 42 patients with AA amyloidosis associated with 
rheumatoid arthritis the ten-year survival was 18 percents and was 
adversely impacted by the presence of azotemia and/or cardiac 
involvement at the time of diagnosis
14). 
Successful treatment of the underlying inflammatory process 
can lead to stabilization of or improvement in renal function, 
reduction in protein excretion, and partial resolution of amyloid 
deposit
15). Therefore, the decision was made to perform more 
aggressive treatments to decrease the frequency of recurrent 
infection originating from bronchiectasis and it was believed that 
this treatment could ultimately put off the progression of renal 
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both patients with and without amyloidosis and this indicates that 
additional factors must be involved in pathogenesis
16, 17). 
In spite of aggressive evaluations, the cause of bronchiectasis in 
our patient was not revealed, but we could rule out CF and ciliary 
dyskinesia which are major causes of bronchiectasis by several 
evaluations such as sweat test, study of CFTR gene and mucosal 
biopsy on nasal cavity. To our knowledge, this report is the first 
case of secondary renal amyloidosis induced by non-CF related 
bronchiectasis in Korean children. 
References
  1)  Ensari C, Ensari A, Tümer N, Ertug E. Clinicopathological and 
epidemiological analysis of amyloidosis in Turkish patients. Nephrol Dial 
Transplant 2005;20:1721-5. 
 2)  Woo P. Amyloidosis in children. Baillieres Clin Rheumatol 1994;8:691-7.
 3)  Redding GJ. Bronchiectasis in children. Pediatr Clin North Am 2009; 
56:157-71.
 4)  Glenner GG. Amyloid deposits and amyloidosis The beta-fibrilloses (first 
of two parts). N Engl J Med 1980;302:1283-92.
 5)  Kaltenis P, Mudeniené V, Maknavicius S, Seinin D. Renal amyloidosis 
in a child with chronic granulomatous disease and invasive aspergillosis. 
Pediatr Nephrol 2008;23:831-4.
 6)  Simşek B, Bayazit AK, Ergin M, Soran M, Dursun H, Kilinc Y. 
Renal amyloidosis in a child with sickle cell anemia. Pediatr Nephrol 
2006;21:877-9.
 7)  Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, et al. A 
retrospective analysis for aetiology and clinical findings of 287 secondary 
amyloidosis cases in Turkey. Nephrol Dial Transplant 2002;17:2003-5.
 8)  Moon JH, Lee SJ, Kang MS, Chung WY. A case of secondary renal 
amyloidosis in children with juvenile rheumatoid arthritis. J Korean Soc 
Pediatr Nephrol 2002;6:243-50.
 9)  Demir M, Kutlucan A, Sezer MT. Renal amyloidosis in a patient with 
Kartagener syndrome. Ren Fail 2007;29:117.
10)  Ahn KM, Park HY, Lee JH, Lee MG, Kim JH, Kang IJ, et al. Cystic 
fibrosis in Korean children: a case report identified by a quantitative 
pilocarpine iontophoresis sweat test and genetic analysis. J Korean Med 
Sci 2005;20:153-7. 
 11)  Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E. Non-cystic-
fibrosis bronchiectasis in children: a persisting problem in developing 
countries. Respiration 2005;72:233-8.
  12)  Akçay S, Akman B, Ozdemir H, Eyüboğlu FO, Karacan O, Ozdemir N. 
Bronchiectasis-related amyloidosis as a cause of chronic renal failure. Ren 
Fail 2002;24:815-23.
13)  Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid 
load and clinical outcome in AA amyloidosis in relation to circulating 
concentration of serum amyloid A protein. Lancet 2001;358:24-9.
14)  Tanaka F, Migita K, Honda S, Fukuda T, Mine M, Nakamura T, et al. 
Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp 
Rheumatol 2003;21:343-6.
  15)    Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin 
CA, Gillmore JD, et al. Natural history and outcome in systemic AA 
amyloidosis. N Engl J Med 2007;356:2361-71.
  16) De Beer FC, Mallya RK, Fagan EA, Lanham JG, Hughes GR, Pepys 
MB. Serum amyloid-A protein concentration in inflammatory diseases 
and its relationship to the incidence of reactive systemic amyloidosis. 
Lancet 1982;2:231-4.
17)  Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 
alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998; 
5:262-5.